Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04735796
Title Study of LM-102 in Subjects in Advanced Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors LaNova Medicines Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarcoma Oncology Research Center, Cancer Center of Southern California California City California 201203 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Henry Ford Cancer Institute Detroit Michigan 48202 United States Details
Gabrail Cancer and Research Center Canton Ohio 44718 United States Details
Oklahoma University- Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field